Geode Capital Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-197,855
| Closed | -$205K | – | 4299 |
|
|
2019
Q1 | $205K | Buy |
197,855
+24,292
| +14% | +$19.8K | ﹤0.01% | 3737 |
|
|
2018
Q4 | $129K | Buy |
173,563
+46,083
| +36% | +$69.4K | ﹤0.01% | 3813 |
|
|
2018
Q3 | $270K | Buy |
127,480
+10,150
| +9% | +$24.3K | ﹤0.01% | 3667 |
|
|
2018
Q2 | $271K | Hold |
117,330
| – | – | ﹤0.01% | 3638 |
|
|
2018
Q1 | $373K | Hold |
117,330
| – | – | ﹤0.01% | 3498 |
|
|
2017
Q4 | $481K | Sell |
117,330
-7,239
| -6% | -$31.5K | ﹤0.01% | 3370 |
|
|
2017
Q3 | $563K | Hold |
124,569
| – | – | ﹤0.01% | 3316 |
|
|
2017
Q2 | $414K | Sell |
124,569
-40,319
| -24% | -$167K | ﹤0.01% | 3423 |
|
|
2017
Q1 | $1.52M | Sell |
164,888
-1,075
| -0.6% | -$9.44K | ﹤0.01% | 2799 |
|
|
2016
Q4 | $1.28M | Buy |
165,963
+27,457
| +20% | +$252K | ﹤0.01% | 2876 |
|
|
2016
Q3 | $1.58M | Buy |
138,506
+31,524
| +29% | +$367K | ﹤0.01% | 2695 |
|
|
2016
Q2 | $1.32M | Buy |
106,982
+4,893
| +5% | +$59.4K | ﹤0.01% | 2747 |
|
|
2016
Q1 | $1.03K | Sell |
102,089
-73
| -0.1% | -$857 | ﹤0.01% | 2866 |
|
|
2015
Q4 | $2.3M | Buy |
102,162
+10,845
| +12% | +$222K | ﹤0.01% | 2386 |
|
|
2015
Q3 | $1.51M | Sell |
91,317
-2,873
| -3% | -$57.6K | ﹤0.01% | 2622 |
|
|
2015
Q2 | $2.12M | Buy |
94,190
+23,016
| +32% | +$568K | ﹤0.01% | 2464 |
|
|
2015
Q1 | $1.83M | Buy |
71,174
+2,147
| +3% | +$54.5K | ﹤0.01% | 2494 |
|
|
2014
Q4 | $1.5M | Buy |
69,027
+7,915
| +13% | +$162K | ﹤0.01% | 2604 |
|
|
2014
Q3 | $1.16M | Buy |
61,112
+24,431
| +67% | +$491K | ﹤0.01% | 2700 |
|
|
2014
Q2 | $854K | Buy |
36,681
+5,760
| +19% | +$142K | ﹤0.01% | 2889 |
|
|
2014
Q1 | $1.04M | Buy |
30,921
+1,399
| +5% | +$47.1K | ﹤0.01% | 2779 |
|
|
2013
Q4 | $871K | Buy |
29,522
+1,878
| +7% | +$34.4K | ﹤0.01% | 2802 |
|
|
2013
Q3 | $423K | Buy |
+27,644
| New | +$512K | ﹤0.01% | 3023 |
|
Geode Capital Management's OMED Position: Q2 2019 in Review
Geode Capital Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 197,855 shares — an estimated $205K sold.
Geode Capital Management first reported a position in OMED in Q3 2013 and held it in 23 quarters. The position peaked at $2.3M in Q4 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- Geode Capital Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- Geode Capital Management sold 197,855 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $205K.
- Geode Capital Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 23 quarters.
- Geode Capital Management's OncoMed Pharmaceuticals, Inc. position peaked at $2.3M in Q4 2015.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on Geode Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.